Degraded protein complexes

Degraded protein complexes are pathological accumulations of damaged or misfolded proteins that have lost their native structure and function, often forming insoluble aggregates within tissues. In ophthalmology, these complexes primarily involve crystallin proteins in the lens that aggregate due to oxidative stress and aging, resulting in the clouding characteristic of cataracts [1, 2]. These aggregates are the primary target for novel pharmacological interventions like C-KAD (edetate disodium), which is designed to break up these complexes and restore lens transparency [6, 7]. Similar proteinaceous deposits, such as lipofuscin or amyloid aggregates, are central to the pathogenesis of neurodegenerative diseases and skin aging, where they impair cellular proteostasis [9, 10]. Therapeutic strategies targeting these complexes focus on disaggregation, solubilization, or the enhancement of endogenous clearance pathways like autophagy and the proteasome system [4, 9]. Consequently, while 'degraded protein complexes' represents a heterogeneous group of proteins rather than a single molecular entity, they serve as a critical focal point for treating various age-related and protein-misfolding disorders.

Other names

Protein aggregatesLens protein aggregatesCrystallin aggregatesMisfolded protein complexesLipofuscinProteinaceous deposits

Disaggregation and solubilization of pathological protein aggregates to restore tissue transparency or cellular function.